Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia
Monica C Robotin,1–3 Ximena Masgoret,1 Mamta Porwal,4 David Goldsbury,5 Chee Khoo,6,7 Jacob George,2,3 1School of Medicine, The University of Notre Dame Australia, Darlinghurst, 2Faculty of Medicine, University of Sydney, Camperdown, 3Storr Liver Center, Westmead Institute for Medical Rese...
Main Authors: | Robotin MC, Masgoret X, Porwal M, Goldsbury D, Khoo C, George J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Clinical Epidemiology |
Subjects: | |
Online Access: | https://www.dovepress.com/using-a-chronic-hepatitis-b-registry-to-support-population-level-liver-peer-reviewed-article-CLEP |
Similar Items
-
Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
by: D T Abdurakhmanov
Published: (2013-10-01) -
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01) -
Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus
by: Shuling Wu, et al.
Published: (2023-01-01) -
Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
by: Peng Wang, et al.
Published: (2023-06-01) -
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
by: Jaemin Lee, et al.
Published: (2016-09-01)